Sort   by:  
 Page size 
UnknownMYL-1402O: A Bevacizumab Biosimilar.
Not available
S-EPMC9015968 | biostudies-literature
ProteomicsClinical efficacy and biomarker analysis of stereotactic body radiotherapy combined with sintilimab and a bevacizumab biosimilar in anti-PD-1 refractory hepatocellular carcinoma
Immune checkpoint inhibitor (ICI) resistance in advanced hepatocellular carcinoma (HCC)poses a major therapeutic challenge. Here, we report a phase 2 trial evaluating stereotactic bodyradiotherapy (SBRT) combined with the anti-PD-1 antibody sintilimab and bevacizumabbiosimilar (lBI305) to re-sensiti...
ORGANISM(S): Homo sapiens (Human) 
2025-10-15 | PAD000004 | Pride
Sintilimab Bevacizumab biosimilar Anti-pd-1 refractory hepatocellular carcinoma Biomarkers of efficacy Stereotactic body radiotherapy 
UnknownReal-World Evidence for Comparative Outcomes between Innovator and Biosimilar Bevacizumab in Advanced Colorectal Cancers.
Not available
S-EPMC11888807 | biostudies-literature
UnknownReal-world outcomes among patients with metastatic colorectal cancer treated first line with a bevacizumab biosimilar (bevacizumab-awwb).
Not available
S-EPMC10288425 | biostudies-literature
UnknownDevelopment of the Drug Product Formulation of the Bevacizumab Biosimilar PF-06439535 (Bevacizumab-bvzr).
Not available
S-EPMC9985529 | biostudies-literature
UnknownComparison of efficacy and safety of bevacizumab biosimilar and original bevacizumab in non-squamous non-small cell lung cancer: a systematic review and meta-analysis.
Not available
S-EPMC9273685 | biostudies-literature
UnknownA phase I, randomized, single-dose pharmacokinetic study comparing sb8 (bevacizumab biosimilar) with reference bevacizumab in healthy volunteers.
Not available
S-EPMC7515939 | biostudies-literature
UnknownExposure-response analysis using time-to-event data for bevacizumab biosimilar SB8 and the reference bevacizumab.
Not available
S-EPMC10825021 | biostudies-literature
UnknownInitial Experience With Biosimilar Bevacizumab-bvzr For Intravitreal Use in Children: A Case Series and Literature Review.
Not available
S-EPMC10874225 | biostudies-literature
UnknownOcular Safety and Toxicokinetics of Bevacizumab-bvzr (Zirabev), a Bevacizumab Biosimilar, Administered to Cynomolgus Monkeys by Intravitreal Injection.
Not available
S-EPMC10079248 | biostudies-literature
Sort   by:  
 Page size